Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.7122
+0.0229 (3.32%)
At close: Aug 4, 2026, 4:00 PM EDT
0.7190
+0.0068 (0.95%)
After-hours: Aug 4, 2026, 4:16 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $192.04 million as of August 4, 2026. Its market cap has decreased by -45.70% in one year.
Market Cap
192.04M
Enterprise Value
203.82M
1-Year Change
-45.70%
Ranking
Category
Stock Price
$0.71
ChartMarket Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $192.04M, an increase of 54.48%. That is a compound annual growth rate of 7.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 192.04M | 3.59% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunic | 191.45M |
| Minerva Neurosciences | 190.55M |
| Protalix BioTherapeutics | 190.15M |
| Pyxis Oncology | 185.95M |
| NovaBridge Biosciences | 183.88M |
| MediWound | 180.77M |
| Precision BioSciences | 180.36M |
| Voyager Therapeutics | 179.99M |